Table 2.
Clinical and biochemical parameters at month 0, major concomitant medication at enrollment
| Parameter | All Patients(n = 647) | High-Flux(n = 318) | Low-Flux(n = 329) |
|---|---|---|---|
| Predialysis BP (mmHg; mean ± SD) | |||
| systolic | 143 ± 21 | 142 ± 21 | 143 ± 22 |
| diastolic | 79 ± 12 | 79 ± 12 | 79 ± 12 |
| Hematocrit (%; mean ± SD) | 33.3 ± 4.6 | 33.6 ± 4.7 | 33.0 ± 4.6 |
| Iron (μg/dl; mean ± SD) | 65.1 ± 31.1 | 67.7 ± 33.8 | 62.7 ± 28.1 |
| Total cholesterol (mg/dl; mean ± SD) | 189.8 ± 46.3 | 185.9 ± 41.1 | 193.5 ± 50.6 |
| LDL (mg/dl; mean ± SD) | 113.5 ± 40.1 | 111.2 ± 36.9 | 115.8 ± 43.0 |
| HDL (mg/dl; mean ± SD) | 44.4 ± 13.9 | 45.1 ± 13.2 | 43.8 ± 14.5 |
| Triglycerides (mg/dl; mean ± SD) | 174.6 ± 127.5 | 165.9 ± 99.7 | 182.7 ± 148.9 |
| Patients on antihypertensive therapy (%) | 85.3 | 85.2 | 85.4 |
| Patients on erythropoietin (%) | 84.5 | 83.6 | 85.4 |
| Patients on lipid-lowering agents (%) | 13.3 | 10.7 | 15.8 |